That’s actually more worrying! As the more shares are bought the more the price goes up?
And loading up on shares in these company means nothing to me, as I had over 66k in shares in one company that consolidated recently and another had over 400k!
Well give me a proper date when it’ll be CE MARK then
Is that your guess do let me know if you actually win lol
I invest in companies having researched the competition to find what I consider to be those best placed to succeed in what is still a frontier market.
I see Kanabo as having all the components required to be a front runner as the market opens up.
But patience is required and whether the SP is 2p or 22p unless you are looking to sell it doesn’t matter. When they increase revenue is when we will see the results we have all been waiting for in the value of the company, next year I expect to see things start to move but that’s just my best guess.
But surely if the revenue is doing good and increased think it was your post above? The share price should be increasing or at least stable! It’s constantly dropping? Like the other CBD company’s!
I’m not hiding my intentions probably like a good 80% of investors on here if it gets near the 22p I’ll be selling and jumping for joy but a lot of people are probably AVG down or better then my .2272 AVG
So that’s why I’m not positive in the SP increase! I don’t see it but too far in to throw it out!
Wow and is that just in that stock? Yea you ain’t going nowhere are you
That’s all you can be! You must be tempted if it was to go to 7p must be near 80k of shares
If only. Revenue is indeed going north every quarter but it helps to remind ourselves that they are operating in a novel field. Add to the mix a market beset by high inflation and interest rates and you have a complete lack of apetite for investment for anything that isnt either bond, savings or defensive, or even just cash. Looking at the macro, I see no reason for new investors to put money in. But then, given the trajectory of the share price unless there is no choice there is little reason to sell up.
The two positive signs for me is the reduction of debt and recent addition of a new company to TreatIt (Kanabo’s telehealth prescription service). Revenue is great but cutting debt in this macro climate I take to be encouraging.
Down £8k now, whatever happens in the long run I expect this to be a success. Obviously I would rather have bought @ 1.3p as I would have over a million shares. But I am still happy if these get to a £ at some point over the next couple of years, which is what I bought in for.
Smart move here, I might have to have a word with one of our green councillors. Every council should follow this lead, a great way to help remove the stigma around medicinal cannabis.
Looks like he could be of Jewish origin, they know their cannabinoids.
It’s still quite pricey, beyond the pocket of many as a regular treatment as compared to free prescriptions on the NHS.
But as you say the German medical market looks well suited to Kanabo’s pod and cartridges.
You could be spot on Chris in it will be the Germans who save us
Good article from the BBC, it’s this evidence based approach the government and NHS are touting that plays so well into Kanabo strategy. They are involved with project 21 so evidence of efficacy of their products has been gathered for some time now. The medical grade metering also helps to present their products as being of consistent high grade suitable for pharmaceutical prescribing.
So we should be at the front of the line when it comes to the market opening up and product being welcomed to market, once the CE is concluded.
iNews has since reported that Atkins has recused herself from dealing with issues related to medical cannabis due to her husband’s position at British Sugar, the company which supplies cannabis for the manufacture of licensed cannabis-based medicine, Epidyolex.
do let me know if you actually win lol
